A5009910312- Immunotherapy and Immune Responses
- Cardiovascular Function and Risk Factors
- Artificial Intelligence in Healthcare
- Lipid metabolism and disorders
- Glycosylation and Glycoproteins Research
- Animal Behavior and Reproduction
- Healthcare Systems and Challenges
- Hepatitis B Virus Studies
- Diffusion and Search Dynamics
- Pediatric health and respiratory diseases
- Risk and Safety Analysis
- Multiple Myeloma Research and Treatments
- PARP inhibition in cancer therapy
- Heart Failure Treatment and Management
- SARS-CoV-2 and COVID-19 Research
- Toxin Mechanisms and Immunotoxins
- Monoclonal and Polyclonal Antibodies Research
- Ovarian cancer diagnosis and treatment
- Ocular Surface and Contact Lens
- Urticaria and Related Conditions
- Wildlife Ecology and Conservation
- Primary Care and Health Outcomes
University of Oxford
2017-2020
University of Essex
2017
Texas Medical Center
1978
Indiana University
1975
Understanding how an individual animal is able to navigate through its environment a key question in movement ecology that can give insight into observed patterns and the mechanisms behind them. Efficiency of navigation important for behavioral processes at range different spatio-temporal scales, including foraging migration. Random walk models provide standard framework modeling navigation. Here we consider vector-weighted biased correlated random (BCRW) model directed (taxis), where...
<h3>Introduction/Background</h3> The approval of poly(ADP-ribose) polymerase inhibitors (PARPi) as first-line maintenance (1LM) provided a new frontline treatment option for patients with advanced ovarian cancer (aOC) in the UK. objective this real-world study was to describe patient characteristics and patterns pre- post-2018 examine how 1LM PARPi changed aOC landscape England. <h3>Methodology</h3> This retrospective used anonymized electronic health record-derived data from UK Arcturis set...
I was amazed to read that GP practices have three separate sources of funding for influenza immunisation campaigns (clinical digest June 14). Practices are paid £7.51 per jab, and the cost is reimbursed in England Wales when it bought administered by practice. There also generous payments attaining targets managing chronic disease.
e20025 Background: It is increasingly challenging and ethically questionable to recruit patients on control arms when a vast body of information readily available through electronic health records (EHR). Synthetic Control Arms (SCA) may reduce the time cost running trial, ultimately alleviate patient burden. This study explores potential SCAs derived from EHR provide additional support for trials investigating treatment efficacy in multiple myeloma (MM). Methods: De-identified UK NHS trust...
Biomedical research is increasingly employing real world evidence (RWE) to foster discoveries of novel clinical phenotypes and better characterize long term effect medical treatments. However, due limitations inherent in the collection process, RWE often lacks key features patients, particularly when these cannot be directly encoded using data standards such as ICD-10. Here we propose a data-driven statistical machine learning approach, named Feature Imputation via Local Likelihood (FILL),...
Biomedical research is increasingly employing real world evidence (RWE) to foster discoveries of novel clinical phenotypes and better characterize long term effect medical treatments. However, due limitations inherent in the collection process, RWE often lacks key features patients, particularly when these cannot be directly encoded using data standards such as ICD-10. Here we propose a data-driven statistical machine learning approach, named Feature Imputation via Local Likelihood (FILL),...